NorFalk’s Post

So HAPPY to have been at the launch of the BioIndustry Association (BIA) Deepbiotech report, and their commitment to the non-therapeutic side of biotech. You might have gathered that it is this part of biotech that I'm particularly in love with. The bits of high-tech biotech that we will see in our clothes, cars, food, beauty potions lotions, houses. That will BE our houses. One day. Soon. Amazing panel chaired by the wonderful Linda Bedenik. Isabel Webb on the panel, just one of at least 3 Engineering Biology Department for Science, Innovation and Technology team members there. The biotech community is very lucky to have Izzy, Mark Renshaw and Jack Weaver (and the growing team) on their side. I get about a bit, go to quite a few events, and at about 90% of them, one of their team are there, talking to you all and finding out what's on your mind. And Rita Cruz giving the perspective of a well established biotech Ingenza Ltd, the changes she's seen over the years and the funding landscape for early stage (non-therapeutic) biotechs. The community is SO nice (lovely to see so many of you again Kerstin Kinkelin James MacDonald Tim Corcoran Manuel Rios Krauss Isabel Zhang) - if you are in biotech and you don't get to many events, I can make you a list 😁 And if you aren't in the BIA yet because it only does life sciences... Well... That is now incorrect and there are already a lot of non therapeutic biotechs (deep biotechs) in the BIA - having their say and helping to influence the landscape for you all. Why not join them? Check out the report here (it even has its own website!) https://deepbiotech.org/ #syntheticbiology #biotechnology #innovation #founders #postdoc #startups #phd

Exciting News! 🎉 We are thrilled to announce that our startup Anti Bone Breaking has been selected to be a part of the prestigious BIGinBIO program, powered by GaneshaLab! It is with great pride and excitement that we share this incredible milestone with our valued community. Being chosen to join BIGinBIO is a proof to the potential and innovation of our ionic calcium supplement and its ability to revolutionize the field of bone health. BIGinBIO, led by the esteemed team at GaneshaLab, is a renowned scale-up and investment program dedicated to supporting and nurturing high-growth startups in the biotechnology sector. This program will provide us with invaluable resources, mentorship, and access to a vast network of industry experts and investors. We are immensely grateful for this opportunity to further accelerate our growth, refine our strategies, and propel our mission forward. With GaneshaLab's expertise and guidance, we are confident that we can make an even greater impact on the lives of individuals affected by osteoporosis and related conditions. We extend our heartfelt appreciation to our remarkable team, advisors, partners, and supporters who have played an integral role in our journey thus far. Your unwavering belief in our vision and dedication to our mission have brought us to this incredible moment. Stay tuned as we embark on this exciting chapter with BIGinBIO and GaneshaLab. Together, we are poised to achieve remarkable milestones, advance bone health research, and transform the future of calcium supplementation. #startup #scaleup #investment #biotechnology #bonehealth #innovation #BIGinBIO #biotech #entrepreneurs #science

Article: https://lnkd.in/eTJ84ww6 This article showcases our top picks for the best North Carolina based Genetics companies. These startups and companies are taking a variety of approaches to innovating the Genetics industry, but are all exceptional companies well worth a follow. We tried to pick companies across the size spectrum from cutting edge startups to established brands. We selected these startups and companies for exceptional performance in one of these categories: Innovation - Innovative ideas - Innovative route to market - Innovative product Growth - Exceptional growth - Exceptional growth strategy Management Societal impact Featuring: Precision BioSciences, Inc. Celldom, Inc. @metalytics-llc @linkedin.com Wyeth BioPharma Duke Clinical Research Institute MOLTOX 108Labs Gentris | A CGI Company @linkedin.com @cogenicsconsulting @phenogen-sciences-inc- GeneType General Biosystems, Inc nSight Labs, Inc

🔬 PulmoBioMed - a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions - has raised £1.4m to help commercialise its technology and target the US market. PulmoBioMed's breath sampling technology offers a fast, non-invasive way to obtain fluid samples from the deep lung without contamination from fluids from the mouth. The investment round was led by The North East Fund Ltd supported by the European Regional Development Fund and managed by Mercia Ventures, and included Northumbria University, SFC Capital and private investors in the USA, EU and UK. The company has also secured a £700,000 grant from Innovate UK to help it demonstrate the benefits of its technology. More ⏬ #NEVF #Innovation #BioMed #Diagnosis #Asthma #BioTech #Technology #NorthEast #Investment #VentureCapital #Entrepreneurship #Internationalisation

👏 Congratulations! 👏  🏅 Gate Bioscience, a #biotechnology startup located in #California, has secured $60 million in a series A fundraising round. Versant Ventures and a16z Bio + Health led the #funding effort, with participation from GV and ARCH Venture Partners....#funding.  The money will be used by the business for both its operations and growth initiatives. #Molecular Gates is a new class of #medications being developed by Gate Bioscience, a preclinical biotech business led by CEO Jordi Mata-Fink 🏅  💼 At Checkmate Equity, our cap table experts are here for YOU 💼  ✨ We offer swift and precise updates to your cap table. ✨  📊 Whether you need help onboarding onto platforms like Carta, need assistance managing your cap table on an ongoing basis, or need a cap table audit – we've got your startup's back! 📊 #StartupSuccess #CheckmateEquity #CapTable #PremierOnboarding #EquityAdministration #CapTableAudit #Carta

Exciting News! 🎉 We are thrilled to announce that our startup Anti Bone Breaking has been selected to be a part of the prestigious BIGinBIO program, powered by GaneshaLab! It is with great pride and excitement that we share this incredible milestone with our valued community. Being chosen to join BIGinBIO is a proof to the potential and innovation of our ionic calcium supplement and its ability to revolutionize the field of bone health. BIGinBIO, led by the esteemed team at GaneshaLab, is a renowned scale-up and investment program dedicated to supporting and nurturing high-growth startups in the biotechnology sector. This program will provide us with invaluable resources, mentorship, and access to a vast network of industry experts and investors. We are immensely grateful for this opportunity to further accelerate our growth, refine our strategies, and propel our mission forward. With GaneshaLab's expertise and guidance, we are confident that we can make an even greater impact on the lives of individuals affected by osteoporosis and related conditions. We extend our heartfelt appreciation to our remarkable team, advisors, partners, and supporters who have played an integral role in our journey thus far. Your unwavering belief in our vision and dedication to our mission have brought us to this incredible moment. Stay tuned as we embark on this exciting chapter with BIGinBIO and GaneshaLab. Together, we are poised to achieve remarkable milestones, advance bone health research, and transform the future of calcium supplementation. #startup #scaleup #investment #biotechnology #bonehealth #innovation #BIGinBIO #biotech #entrepreneurs #science #startups #health #research

“Not all money is created equal. Raise money from investors who are strategically aligned with your mission. Early-stage companies are vulnerable. Strong support from the investors is essential. To the extent possible, raise the first round from investors who have the means to continue to support in subsequent rounds. Talk to as many people as possible. There is a saying. If you want money, ask for advice. If you want advice, ask for money.” Samir Mitragotri - Professor @ Harvard University / Core Faculty @ Wyss Institute for Biologically Inspired Engineering Learn More: The Mitragotri Lab @ http://ow.ly/rXB150IBzMS Companies Founded: 14 startups - Including: Sontra Medical, YourBio Health, CAGE Bio Inc., Fount Bio, Inc., i2o Therapeutics, among many others. Listen to our podcast w/ Samir... http://ow.ly/X5Jk50IBzMT For more on Harvard entrepreneurship, checkout: http://ow.ly/9lAn50IBzMU #startups #lifesciences #venturecapital #genomics #biotechnology #biotech #research #biology #science #healthcare #innovation #engineering #founders #syntheticbiology #startup #pharma #entrepreneurship #patientimpact #phd #VC

“Due your due diligence. The VCs are doing their homework on you. You should do the same. Talk to other colleagues and see who they have worked with and get intros. It matters who introduces you to a firm (like who introduces you to a graduate student or postdoc mentor!). It’s a big deal since these folks will be with you for years and early VCs (may) take on board seats in the company and have control and a big say in the running of the business.” Carlos D. Bustamante - Professor @ Stanford University / CEO & Co-Founder @ Galatea Bio Inc. Learn More: The Bustamante Lab @ http://ow.ly/IYqb50IEyrf Companies Founded: Arc Bio, CDB Consulting LTD, Galatea Bio Inc., Etalon Inc, FaunaBio, Embark Veterinary, amongst others. For more on Stanford entrepreneurship, checkout: http://ow.ly/MQB250IEyre #startups #lifesciences #venturecapital #genomics #biotechnology #biotech #research #biology #science #healthcare #innovation #engineering #founders #syntheticbiology #startup #pharma #entrepreneurship #patientimpact #phd #VC #university #leadership #ceo

Latvian LongeVC has invested in the US startup CatenaBio. The total amount of the extended seed round was $2.35M. Existing #investors California Innovation Fund, the US Civilization Ventures and Pioneer Fund, and new investors Freeflow from the US, Californian Caffeinated Capital, and the BrightEdge - American Cancer Society participated in the round. Founded in 2020 by Marco Lobba, Ph.D., Geo Guillen, and Matthew Francis and spun out of the laboratory at the University of California, Berkeley, CatenaBio has developed a platform, that allows the creation of novel biomolecules and further synthesizes them in any structure, combination, or orientation. Using naturally occurring amino acids, the startup’s technology allows coupling proteins to create novel therapeutics in autoimmune diseases, #oncology, and vaccine development. Autoimmune diseases cause the body to attack healthy cells, but Catena’s protein conjugation technique allows scientists to attach safe signals to healthy cells, tricking the immune system into no longer attacking them. The startup plans to raise its next Series A later this year. LongeVC is a venture company with offices in #Riga and #Lugano (#Switzerland). It was established in 2016 by Garri Zmudze, Sergey Jakimov, and Ilya Suharenko. A €35M fund backs startups at the early and seed stages across the US and Europe. All about Baltic startups and VC https://www.balticvc.com/ #Latvia #startup #startups #tech #technology #technologies #TechnologyNews #TechNews #Deal #Deals #VentureCapital #VC #biotech #Biotechnology #Science #medtech